|
TATDN1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.564000E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.020180E-02 |
| Normal-vs-Stage2 |
1.448350E-02 |
| Normal-vs-Stage3 |
1.519580E-01 |
| Normal-vs-Stage4 |
4.764200E-01 |
| Stage1-vs-Stage2 |
3.497200E-01 |
| Stage1-vs-Stage3 |
4.005600E-01 |
| Stage1-vs-Stage4 |
1.927960E-01 |
| Stage2-vs-Stage3 |
1.949380E-01 |
| Stage2-vs-Stage4 |
9.101700E-02 |
| Stage3-vs-Stage4 |
5.909400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.624200E-02 |
| Normal-vs-AfricanAmerican |
8.917800E-01 |
| Normal-vs-Asian |
1.344360E-02 |
| Caucasian-vs-AfricanAmerican |
2.812000E-01 |
| Caucasian-vs-Asian |
2.573800E-01 |
| AfricanAmerican-vs-Asian |
8.002500E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.883800E-03 |
| Normal-vs-Female |
3.892300E-02 |
| Male-vs-Female |
2.080600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.194500E-02 |
| Normal-vs-Age(41-60Yrs) |
3.828500E-02 |
| Normal-vs-Age(61-80Yrs) |
1.225010E-01 |
| Normal-vs-Age(81-100Yrs) |
2.482300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.514600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.999400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.655800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.883600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.187600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.942000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.864200E-01 |
| Classical-VS-Follicular |
3.032300E-02 |
| Classical-VS-Other |
8.610200E-01 |
| Classical-VS-Normal |
7.508200E-02 |
| Tall-VS-Follicular |
3.636400E-02 |
| Tall-VS-Other |
7.518600E-01 |
| Tall-VS-Normal |
8.936200E-01 |
| Follicular-VS-Other |
4.176800E-01 |
| Follicular-VS-Normal |
2.098500E-03 |
| Other-VS-Normal |
7.588800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.162190E-03 |
| Normal-vs-N1 |
8.062400E-02 |
| N0-vs-N1 |
4.155200E-01 |
|
|
